ID

12498

Description

Study documentation part: Adverse event. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Görge, University Hospital of Münster. EudraCT - Nr. 2012-000108-13.

Keywords

  1. 11/24/15 11/24/15 -
  2. 11/24/15 11/24/15 - Julian Varghese
Uploaded on

November 24, 2015

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Riliva_CRF_EudraCT - Nr. 2012-000108-13- Adverse event DRKS00004652

Riliva_CRF_EudraCT - Nr. 2012-000108-13- Adverse event

Adverse event
Description

Adverse event

Alias
UMLS CUI-1
C0877248
Adverse event
Description

Adverse event

Data type

text

Alias
UMLS CUI [1]
C0877248
Start date of adverse event
Description

Start date

Data type

date

Alias
UMLS CUI [1]
C0808070
Serious Adverse Event
Description

Serious Adverse Event

Data type

boolean

Alias
UMLS CUI [1]
C1519255
Intensity
Description

Symptom intensity

Data type

text

Alias
UMLS CUI [1]
C0518690
Relation to study medication
Description

medication study; Relations

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0869014
Measures taken regarding study medication
Description

medication study; Measures

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0079809
Adverse event leading to study discontinuation
Description

Adverse Event Caused Study Discontinuation

Data type

boolean

Alias
UMLS CUI [1]
C2826233
Adverse event end date
Description

Adverse Event End Date

Data type

date

Alias
UMLS CUI [1]
C2697886
Adverse Event Outcome
Description

Adverse Event Outcome

Data type

text

Alias
UMLS CUI [1]
C1705586

Similar models

Riliva_CRF_EudraCT - Nr. 2012-000108-13- Adverse event

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Adverse event
C0877248 (UMLS CUI-1)
Adverse event
Item
Adverse event
text
C0877248 (UMLS CUI [1])
Start date
Item
Start date of adverse event
date
C0808070 (UMLS CUI [1])
Serious Adverse Event
Item
Serious Adverse Event
boolean
C1519255 (UMLS CUI [1])
Item
Intensity
text
C0518690 (UMLS CUI [1])
Code List
Intensity
CL Item
slight, no effect on daily activities (e.g, cooking, shopping) (1)
CL Item
moderate, daily activity impaired (2)
CL Item
severe, daily activity not possible (3)
Item
Relation to study medication
text
C0013227 (UMLS CUI [1,1])
C0869014 (UMLS CUI [1,2])
Code List
Relation to study medication
CL Item
no reasonable connection (1)
CL Item
reasonable connection (2)
Item
Measures taken regarding study medication
text
C0013227 (UMLS CUI [1,1])
C0079809 (UMLS CUI [1,2])
Code List
Measures taken regarding study medication
CL Item
none (1)
CL Item
dose reduction (2)
CL Item
dose increase (3)
CL Item
temporarily stopped (4)
CL Item
ultimately stopped (5)
CL Item
unknown (6)
CL Item
not applicable (7)
Adverse Event Caused Study Discontinuation
Item
Adverse event leading to study discontinuation
boolean
C2826233 (UMLS CUI [1])
Adverse Event End Date
Item
Adverse event end date
date
C2697886 (UMLS CUI [1])
Item
Adverse Event Outcome
text
C1705586 (UMLS CUI [1])
Code List
Adverse Event Outcome
CL Item
restored (1)
CL Item
improved (2)
CL Item
still not improved (3)
CL Item
restored with permanent damage (4)
CL Item
death (5)
CL Item
unknown (6)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial